NVAITRAK is a binder of HLA-A*11:01, which is associated with autoimmune and inflammatory diseases such as type 1 diabetes (92), diffuse panbronchiolitis (96), and otosclerosis (97). This evidence concerns the gene HLA-A and otosclerosis.